Sudeep Pharma LimitedSUDEEPPHRMCorporate

Pharmaceuticals Latest results: Jun 2026 6 quarters of data

₹1,000.70

MCap ₹11,303 Cr · P/E 61.3

Sudeep Pharma Limited — Stock analysis & AI research Sudeep Pharma Limited — Multibagger AI analysis Sudeep Pharma Limited — Seasonality — best & worst months Sudeep Pharma Limited — Technical indicators & charts Sudeep Pharma Limited — Technical setup — score, trend, support & resistance Sudeep Pharma Limited — Live exchange announcements

📋 High Operating Margin Stocks 📋 High Interest Coverage Stocks 📋 Stocks With Strong Quarterly Results 📋 High Promoter Holding Stocks 🏭 Pharma sector

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹158 Cr

Sales · Jun 2026

+26.6% YoY

₹55 Cr

Operating Profit · Jun 2026

+24.8% YoY

34.7%

OPM % · Jun 2026

-1.4% YoY

₹41 Cr

Net Profit · Jun 2026

+30.9% YoY

₹3.59

EPS · Jun 2026

+13.2% YoY

📝 Sudeep Pharma Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Sudeep Pharma Limited reported revenue of ₹158 crore for the quarter ended June 2026 (Q1 FY27), up 26.6% from ₹125 crore in the same quarter last year, and down 13.0% sequentially over the March 2026 quarter.

Net profit rose 30.9% year-on-year to ₹41 crore, from ₹31 crore. Earnings per share (EPS) came in at ₹3.59.

Operating profit stood at ₹55 crore — an operating margin (OPM) of 34.7%, compared with 35.2% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Sudeep Pharma Limited posted revenue of ₹642 crore, with a net profit of ₹175 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹675 crore with a net profit of ₹184 crore.

Valuation snapshot

At the current price of ₹1,000.70, SUDEEPPHRM has a market capitalisation of ₹11,303 crore and a trailing P/E of about 61.3.

Within the Pharmaceuticals industry, it is the largest of the 82 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 76.15%, foreign institutional investors (FIIs) 2.93%, domestic institutional investors (DIIs) 14.05%, public shareholders 6.87% of Sudeep Pharma Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹11,303 Cr

Current Price ?

₹1,000.7

P/E ?

61.31above ind

Industry P/E ?

22.40

P/B ?

N/A

P/S ?

16.75

P/FCF ?

N/A

Enterprise Value ?

N/A

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

1.6%

Dividend Yield ?

N/A

Profitability & Returns

Sales (TTM) ?

₹675 Cr

OPM ?

34.6%

Profit after tax (TTM) ?

₹184 Cr

EPS (TTM) ?

₹16.32

ROCE ?

N/A

ROE ?

N/A

ROA ?

N/A

Growth

Sales — latest qtr ?

₹158 Cr

PAT — latest qtr ?

₹41 Cr

YoY qtr sales growth ?

26.6%

YoY qtr profit growth ?

30.9%

Sales growth (3y) ?

N/A

Sales growth (5y) ?

N/A

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

N/A

Debt to Equity ?

N/A

Interest Coverage ?

28.5

Current Ratio ?

N/A

Ownership

Promoter holding ?

76.15%

Change in promoter holding ?

0.00%

Pledged percentage ?

N/A

Market

Return 3 months ?

16.0%

Return 6 months ?

55.0%

🗓️ Quarterly results (6 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	158	125	163	172	182	158	+26.6%	-13.0%
Operating Profit	59	44	55	60	63	55	+24.8%	-12.8%
Other Income	4	5	10	7	6	5	+8.9%	-9.2%
Interest	2	2	2	1	2	2	+3.2%	+3.2%
Depreciation	3	3	4	4	4	4	+33.4%	+0.0%
Profit Before Tax	58	44	60	62	63	54	+23.4%	-13.8%
Net Profit	44	31	47	48	49	41	+30.9%	-17.2%
EPS	4.54	3.17	4.20	4.20	4.33	3.59	+13.2%	-17.1%
OPM %	37.3%	35.2%	34.1%	34.9%	34.6%	34.7%	-1.4%	+0.3%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	Prev FY	FY26	TTM	YoY %
Sales	—	₹642 Cr	₹675 Cr	—
Operating Profit	—	₹222 Cr	₹233 Cr	—
OPM %	—	34.67%	34.58%	—
NPM %	—	27.24%	27.32%	—
Other Income	—	₹28 Cr	₹29 Cr	—
Depreciation	—	₹15 Cr	₹16 Cr	—
Interest	—	₹7 Cr	₹7 Cr	—
EBIT	—	₹208 Cr	₹218 Cr	—
PBT	—	₹229 Cr	₹239 Cr	—
Tax	—	₹13 Cr	₹26 Cr	—
Net Profit	—	₹175 Cr	₹184 Cr	—
EPS	—	₹15.90	₹16.32	—
Material Cost	—	₹70 Cr	₹139 Cr	—
Employee Cost	—	₹14 Cr	₹28 Cr	—
Extraordinary Items	—	—	—	—

👥 Shareholding (latest 1 periods)

Metric	Sep 2026	% Chg
Promoters	76.15%	—
FIIs	2.93%	—
DIIs	14.05%	—
Public	6.87%	—
No. of Shareholders	40,465	—

⚖️ Peer comparison

Industry: Pharmaceuticals · top 25 of 82 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	SUDEEPPHRM Sudeep Pharma	₹1,033.30	11,671	63.3	675	184	34.6%	27.3%	—	—	26.6%	30.9%
2	SPARC Sun Pharma	₹185.08	6,006	3.8	1,909	1,584	84.7%	83.0%	2512.3%	553.9%	314.1%	59.9%
3	GUJTHEM Gujarat Themis	₹412.60	5,370	92.3	173	48	47.3%	27.8%	8.6%	-6.1%	21.6%	23.0%
4	539997 Kwality Pharmaceuticals	₹2,652.10	3,525	34.0	553	81	24.4%	14.6%	35.7%	71.8%	46.3%	113.5%
5	524632 Shukra Pharmaceuticals	₹80.95	2,403	99.9	75	36	65.0%	48.2%	74.0%	130.1%	336.4%	1359.2%
6	FERMENTA Fermenta Biotech	₹475.00	1,362	21.4	501	64	18.9%	12.7%	—	—	-17.9%	-30.6%
7	506414 Fermenta Biotech	₹552.60	1,313	27.2	511	59	17.6%	11.5%	11.9%	-6.6%	-10.4%	-56.7%
8	AHCL Anlon Healthcare	₹20.20	1,074	—	—	—	—	—	—	—	163.0%	133.3%
9	541096 Bharat Parenterals	₹1,525.00	1,062	—	323	-30	3.3%	-9.3%	1.5%	37.5%	-19.2%	-309.6%
10	540737 Shree Ganesh	₹796.30	855	66.2	99	15	31.4%	15.6%	0.7%	-23.0%	-41.8%	-67.5%
11	AMANTA Amanta Healthcare	₹197.75	768	52.5	291	15	20.4%	5.0%	—	—	5.4%	-5.6%
12	539730 Fredun Pharmaceuticals	₹827.85	611	10.3	747	44	14.7%	5.9%	40.1%	90.0%	90.2%	88.1%
13	500422 Transchem Ltd-$	₹38.00	474	10.8	—	4	—	—	-100.0%	-17.8%	-100.0%	186.3%
14	HALEOSLABS Haleos Labs	₹1,525.00	461	21.0	324	15	12.6%	4.7%	-3.2%	-4.9%	-11.6%	-58.0%
15	524731 Jenburkt Pharmaceuticals	₹865.75	404	11.6	170	33	23.6%	19.4%	11.8%	6.1%	-1.4%	-26.4%
16	543616 Trident Lifeline	₹279.85	364	14.0	134	24	24.6%	17.9%	—	—	42.6%	44.2%
17	512600 Astal Laboratories	₹75.00	308	32.3	170	10	8.8%	5.7%	142.9%	-9.0%	56.0%	77.4%
18	524828 BDH Industries	₹336.80	300	16.6	100	12	15.3%	11.7%	44.3%	16.6%	20.2%	48.8%
19	500009 Ambalal Sarabhai	₹38.73	297	21.9	206	14	7.1%	6.6%	3.1%	261.1%	8.0%	-51.6%
20	532039 Zenotech Laboratories	₹64.90	263	—	45	-3	17.0%	-5.6%	1.3%	-119.2%	10.1%	-146.0%
21	531739 Gennex Laboratories	₹13.87	255	19.0	183	21	14.4%	11.3%	24.9%	15.5%	16.6%	-6.9%
22	524790 Everest Organics	₹159.20	252	29.4	191	5	10.3%	2.8%	23.0%	527.7%	-10.0%	-21.1%
23	530163 Kerala Ayurveda	₹310.20	225	—	125	-26	-14.9%	-20.8%	9.0%	-16.8%	-21.3%	-477.8%
24	531569 Sanjivani Paranteral	₹199.95	214	32.7	66	7	15.3%	11.3%	-7.6%	-14.4%	8.8%	32.7%
25	524636 Oxygenta Pharmaceutical	₹32.25	195	—	135	-14	-5.9%	-10.1%	3.3%	-70.8%	144.5%	65.6%

❓ Frequently asked questions

What was Sudeep Pharma Limited's revenue in Q1 FY27?

What was Sudeep Pharma Limited's net profit in Q1 FY27?